These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13484916)

  • 1. [Result of application of new drugs in the treatment of leukemia].
    DUL'TSIN MS; BIUR LS; MOKEEVA RA
    Probl Gematol Pereliv Krovi; 1957; 2(4):30-41. PubMed ID: 13484916
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic granulocytic leukemia with myleran.
    UNUGUR A; SCHULMAN E; DAMESHEK W
    N Engl J Med; 1957 Apr; 256(16):727-34. PubMed ID: 13451927
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myleran use in leukaemias].
    LARRAIN C; MEZA ARRAU C; GERBER K; ZUNIGA C
    Rev Med Chil; 1957 Sep; 85(9):534-44. PubMed ID: 13518819
    [No Abstract]   [Full Text] [Related]  

  • 4. [Result of myleran therapy of leukemias in children].
    MUKHAMEDZIANOVA GS
    Pediatriia; 1958 Aug; 22(8):72-5. PubMed ID: 13590890
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and toxicity of intravenous busulfan-based conditioning before allogeneic peripheral blood stem cell transplantation for leukemia].
    Tong XZ; Xu DR; Zou WY; Li J; Luo SK; Peng AH; Zhang GC; Zheng D
    Ai Zheng; 2007 Aug; 26(8):914-8. PubMed ID: 17697559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photo-chemotherapy for graft-versus-host disease.
    Reddy P
    Haematologica; 2005 Aug; 90(8):1013B. PubMed ID: 16079096
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of myleran and similar agents in chronic leukemias.
    GALTON DA
    Adv Cancer Res; 1956; 4():73-112. PubMed ID: 13381607
    [No Abstract]   [Full Text] [Related]  

  • 8. Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients.
    Iravani M; Evazi MR; Mousavi SA; Shamshiri AR; Tavakoli M; Ashouri A; Samiee S; Chahardovali B; Alimoghaddam K; Ghaffari SH; Ghavamzadeh A
    Bone Marrow Transplant; 2007 Jul; 40(2):105-10. PubMed ID: 17468775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic myeloid leukemia by means of a new chemical antiblastic agent, 1-4-dimethylsulfonoxy-butane].
    ESTEVEZ RA
    Prensa Med Argent; 1958 Apr; 45(16):1644-9. PubMed ID: 13601527
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic myeloid leukemia with myleran].
    DE VRIES SI
    Ned Tijdschr Geneeskd; 1958 Feb; 102(8):364-9. PubMed ID: 13541504
    [No Abstract]   [Full Text] [Related]  

  • 11. Morbidity and non-relapse mortality after allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan.
    Kim SE; Lee JH; Choi SJ; Lee JH; Ryu SG; Lee KH
    Haematologica; 2005 Feb; 90(2):285-6. PubMed ID: 15710597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early result of myleran therapy of chronic myeloid leukemias].
    PAWELSKI S; SOBCZYNSKA-CZECHOWSKA Z
    Pol Tyg Lek (Wars); 1957 Oct; 12(43):1650-4. PubMed ID: 13505287
    [No Abstract]   [Full Text] [Related]  

  • 13. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
    Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic myeloleukosis with myelosan.
    PAVLOVSKAIA NI
    Klin Med (Mosk); 1958 Jul; 36(7):82-8. PubMed ID: 13576705
    [No Abstract]   [Full Text] [Related]  

  • 15. Method of treatment of chronic myeloleukosis with myelosan.
    MOKEEVA RA
    Klin Med (Mosk); 1958 Jul; 36(7):89-93. PubMed ID: 13576706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myleran therapy of chronic myeloid leukemia].
    BELER B; ERGUN N
    Turk Tip Cemiy Mecm; 1958 Apr; 24(4):205-8. PubMed ID: 13592964
    [No Abstract]   [Full Text] [Related]  

  • 17. Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.
    Casper J; Knauf W; Blau I; Ruutu T; Volin L; Wandt H; Schafer-Eckart K; Holowiecki J; Giebel S; Aschan J; Zander A; Kroger N; Doelken G; Freund M
    Ann Hematol; 2004; 83 Suppl 1():S70-1. PubMed ID: 15124679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DRUGS IN THE TREATMENT OF LEUKAEMIA.
    ROSS ED; SETTLE JA; TELFER AB
    Br Med J; 1963 Nov; 2(5365):1111-2. PubMed ID: 14057717
    [No Abstract]   [Full Text] [Related]  

  • 19. Conditioning with targeted busulfan for autologous peripheral blood stem cells transplantation for acute myelogenous leukemia in an XYY male.
    Sada E; Henzan H; Ohtani R; Takase K; Miyamoto T; Fukuda T; Nagafuji K; Yamauchi K; Takamatsu Y; Inaba S; Harada M
    Am J Hematol; 2005 Jan; 78(1):55-8. PubMed ID: 15609287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelosan (1,4-dimethanesulfoniloxybutane) and its significance in the therapy of chronic myeloleukosis].
    CHERNOV VA
    Klin Med (Mosk); 1958 Jul; 36(7):73-82. PubMed ID: 13576704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.